Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Tenet Healthcare (THC) Stock?

Natera

Travere Therapeutics

The healthcare sector is vast and includes everything from massive legacy companies including UnitedHealth Group Inc. NYSE: UNH and McKesson Corp. NYSE: MCK to tiny upstart pharmaceuticals firms. Investors looking to explore this sector thus have a choice about whether to focus on established companies with steadier business operations but, perhaps, less of a possibility of future growth, or on smaller firms that offer a higher-risk, higher-reward prospect.

3 Under-the-Radar Healthcare Companies

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?

Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It

BioNTech SE

HCA Healthcare

Humana

Eli Lilly

Pfizer

Universal Health Services

UnitedHealth Group

Health Care Select Sector SPDR Fund

Investors are worried about what a Trump administration means for hospital operators and vaccine makers, but are optimistic about the fate of Medicare Advantage plan providers.

Why most healthcare stocks are falling with Trump's win, with some exceptions

THC continues to experience strong demand for its services, which is expected to continue throughout the year.

Tenet Stock Jumps 19.6% Since Q3 Results: What Should Investors Do?

Tenet Healthcare shares have been scorching-hot in 2024, up 115% and outperforming many of the Mag 7 members.

Bull of the Day: Tenet Healthcare (THC)

Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Tenet (THC) Is Attractively Priced Despite Fast-paced Momentum

Tenet Healthcare is currently shifting towards a more stable demand for high-acuity service. The company is committed to continued expansion and allocated yearly budget to improve its Ambulatory Care Services. Posted an improving margin and has positive outlook from the management.

Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services

THC's Q3 results benefit from higher same-hospital admissions and Medicaid supplemental revenue gains. Cost-cutting measures help offset challenges from hospital divestitures.

Tenet Q3 Earnings Beat on Strong Ambulatory Unit, '24 EPS View Raised

American Airlines

Fortinet

Leidos Hld

Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Leidos (LDOS) and American Airlines (AAL) are likely to beat on the bottom line in their upcoming releases.

Play Likely Earnings Beat With 4 Top-Ranked Stocks

American Assets

Skyline Corp.

Sotherly Hotels

SKY, AAT, SOHO, THC and LDOS have been added to the Zacks Rank #1 (Strong Buy) List on November 1, 2024.

New Strong Buy Stocks for November 1st

Philip Morris

Throughout the Q3 reporting cycle, several companies, including Pfizer, Philip Morris, and Tenet Healthcare, have stolen the spotlight, with each raising guidance.

3 Stocks to Buy Following Robust Quarterly Results

Tenet Healthcare Corporation (NYSE:THC ) Q3 2024 Earnings Conference Call October 29, 2024 10:00 AM ET Company Participants Will McDowell – Vice President-Investor Relations Saum Sutaria – Chairman and Chief Executive Officer Sun Park – Executive Vice President and Chief Financial Officer Conference Call Participants Josh Raskin – Nephron Research Ben Hendrix – RBC Capital Markets A.J. Rice – UBS Stephen Baxter – Wells Fargo Ann Hynes – Mizuho Michael Ha – Baird Pito Chickering – Deutsche Bank Justin Lake – Wolfe Research Joanna Gajuk – Bank of America Whit Mayo – Leerink Partners Andrew Mok – Barclays Brian Tanquilut – Jefferies Matthew Gillmor – KeyBanc Capital Markets Sarah James – Cantor Fitzgerald John Ransom – Raymond James Jamie Perse – Goldman Sachs Operator Good morning, and welcome to Tenet Healthcare's Third Quarter 2024 Earnings Conference Call.

Tenet Healthcare Corporation (THC) Q3 2024 Earnings Call Transcript

Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Tenet Healthcare (THC) came out with quarterly earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.33 per share. This compares to earnings of $1.44 per share a year ago.

Tenet Healthcare (THC) Beats Q3 Earnings and Revenue Estimates

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2024. "Our businesses continue to produce strong results and generate robust free cash flow with same store revenue growth and profitability well above our expectations due to the focused execution of our strategy and disciplined operations," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We have furthered our portfolio transformatio.

Tenet Reports Strong Third Quarter 2024 Results; Raises 2024 Financial Outlook

Besides Wall Street's top -and-bottom-line estimates for Tenet (THC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

Stay Ahead of the Game With Tenet (THC) Q3 Earnings: Wall Street's Insights on Key Metrics

THC's third-quarter results are likely to reflect growing patient admissions, utilization and patient days.

A Dose of Growth? Why Tenet Healthcare Could be a Buy Pre-Q3 Earnings

Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at 12:30 p.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services com.

Tenet to Participate in the UBS Global Healthcare Conference

Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth

In the latest trading session, Tenet Healthcare (THC) closed at $163.87, marking a +1.34% move from the previous day.

Tenet Healthcare (THC) Surpasses Market Returns: Some Facts Worth Knowing

THC is well-positioned to benefit from the growing demand for hospital services. Yet, rising costs can potentially squeeze its margin growth.

Bargain or Bust? Decoding Tenet Healthcare Stock's Lower Valuation

In the latest trading session, Tenet Healthcare (THC) closed at $161.71, marking a -1.41% move from the previous day.

News for Tenet Healthcare Stock (THC)